17 results on '"Kanao, Kent"'
Search Results
2. Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long‐term treatment‐free survival with pembrolizumab and axitinib in the KEYNOTE‐426 phase III trial of pembrolizumab and axitinib versus sunitinib.
- Author
-
Nishimoto, Koshiro, Shirotake, Suguru, Miyama, Yu, Kaneko, Go, Kanao, Kent, Igarashi, Daisuke, Takahashi, Takayuki, Umezawa, Yuta, Yasuda, Masanori, and Oyama, Masafumi
- Published
- 2022
- Full Text
- View/download PDF
3. Laparoendoscopic single‐site simple nephrectomy and reduced port procedure for inflammatory nonfunctioning kidney.
- Author
-
Kaneko, Go, Hattori, Seiya, Shirotake, Suguru, Kanao, Kent, Hara, Satoshi, and Oyama, Masafumi
- Published
- 2021
- Full Text
- View/download PDF
4. Prognostic significance of p16 expression in high‐grade prostate adenocarcinoma.
- Author
-
Takahara, Taishi, Satou, Akira, Sugie, Miho, Watanabe, Masahito, Kanao, Kent, Sumitomo, Makoto, and Tsuzuki, Toyonori
- Subjects
PROSTATE ,PROSTATE cancer ,GLEASON grading system ,CASTRATION-resistant prostate cancer ,NEEDLE biopsy - Abstract
Management of advanced hormone‐naïve prostate cancer (HNPC) is a critical public health issue. Useful prognostic markers are thus needed to select patients who will benefit from recently introduced upfront therapies. p16 expression is an adverse prognostic marker in prostate cancer. The present study aimed to determine whether p16 expression would serve as an adverse prognostic marker in advanced HNPC. A total of 79 patients diagnosed by needle biopsy with adenocarcinoma Gleason score ≥8 between 2010 and 2013 at Aichi Medical University were included in this study. The median patient age was 73 (range 52–87) years. The median follow‐up was 62 months (range 2–98). Fourteen patients had p16‐positive samples. Fifteen patients died from prostate cancer, 10 of whom were in the p16‐positive group. p16 positivity was associated with clinical T stage (P < 0.001), presence of IDC‐P (P < 0.001), distant metastasis (P < 0.001) and lymph node metastasis (P < 0.001). These results indicate that p16 expression is associated with adverse prognostic factor of prostate cancer and suggest that p16 expression may provide useful information for treatment planning and identifying suitable candidates for upfront chemotherapy or androgen receptor axis‐targeted therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis‐assisted transurethral resection involving orally administered 5‐aminolevulinic acid.
- Author
-
Watanabe, Keitaro, Shirotake, Suguru, Umezawa, Yuta, Takahashi, Takayuki, Yamanaka, Takeshi, Santo, Noriaki, Okabe, Takashi, Kaneko, Gou, Sano, Katsuhiro, Yasuda, Masanori, Kanao, Kent, Oyama, Masafumi, and Nishimoto, Koshiro
- Published
- 2019
- Full Text
- View/download PDF
6. Increased infiltration of CCR4‐positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.
- Author
-
Watanabe, Masahito, Kanao, Kent, Suzuki, Susumu, Muramatsu, Hiroyuki, Morinaga, Singo, Kajikawa, Keishi, Kobayashi, Ikuo, Nishikawa, Genya, Kato, Yoshiharu, Zannami, Kenji, Nakamura, Kogenta, Tsuzuki, Toyonori, Yoshikawa, Kazuhiro, Ueda, Ryuzo, and Sumitomo, Makoto
- Published
- 2019
- Full Text
- View/download PDF
7. Impact of a novel biopsy instrument with a 25‐mm side‐notch needle on the detection of prostate cancer in transrectal biopsy.
- Author
-
Kanao, Kent, Kajikawa, Keishi, Kobayashi, Ikuo, Morinaga, Shingo, Muramatsu, Hiroyuki, Nishikawa, Genya, Watanabe, Masahito, Zennami, Kenji, Nakamura, Kogenta, and Sumitomo, Makoto
- Subjects
- *
PROSTATE cancer , *NEEDLE biopsy , *CANCER diagnosis , *HEMATURIA , *MULTIVARIATE analysis - Abstract
Objectives: To evaluate the impact of a novel biopsy instrument that extends the length of the side‐notch on the detection of prostate cancer in transrectal needle biopsy. Methods: We collaborated with a biopsy needle manufacturer and developed a novel biopsy instrument (PRIMECUT II long‐notch type) with a 25‐mm side‐notch length and 28‐mm stroke length to take longer tissue cores. The sampled core length, cancer detection rate, pain and complications of 489 patients who underwent transrectal biopsy using the long‐notch needle were compared with those of 469 patients who underwent biopsy using a normal instrument with a 19‐mm side‐notch length and 22‐mm stroke length. Results: The mean length of tissue taken by the long‐notch needle was significantly longer than that of tissue taken by the normal‐notch needle (16.3 vs 22.4 mm, P < 0.001). The overall cancer detection rate was 42.0% for the normal‐notch needle and 51.1% for the long‐notch needle (P = 0.005). In patients with a prostate volume of 20–40 mL, the cancer detection rate for the long‐notch needle was especially higher than that for the normal‐notch needle (74.2% vs 47.5%, P < 0.001). Multivariate analysis showed that the long‐notch needle improved cancer detection significantly (odds ratio 1.702, P < 0.001). There were no differences of pain during biopsy and complication between the two groups. Conclusions: The novel biopsy instrument with a 25‐mm side‐notch can take longer tissue samples safely and has a significantly higher rate of prostate cancer detection in transrectal biopsy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
8. Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma.
- Author
-
Mizuno, Ryuichi, Kimura, Go, Fukasawa, Satoshi, Ueda, Takeshi, Kondo, Tsunenori, Hara, Hidehiko, Shoji, Sunao, Kanao, Kent, Nakazawa, Hayakazu, Tanabe, Kazunari, Horie, Shigeo, Oya, Mototsugu, Yuasa, T., Horiguchi, A., Nakaigawa, N., Oyama, M., Nagata, H., Ishida, M., Kawata, N., and Hatano, T.
- Abstract
The objective of this prospective study was to identify baseline angiogenic and inflammatory markers in serum as well as the baseline levels of immune cells in whole blood to predict progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib. Blood samples were collected at baseline in all 90 patients to analyze serum angiogenic and inflammatory markers together with peripheral blood immunological marker. The association between each marker and sunitinib efficacy was analyzed. Univariate and multivariate Cox proportional model analyses were used to assess the correlation between those markers with survival. Baseline levels of interleukin-6, interleukin-8, high sensitivity C-reactive protein and myeloid-derived suppressor cells were significantly higher in patients who progressed when compared with those with clinical benefit. Analysis by the Cox regression model showed that baseline interleukin-8, high sensitivity C-reactive protein and percentage of T helper type 1 cells were significantly associated with progression-free survival in univariate analysis. Furthermore, in multivariate analysis, those three markers were independent indices to predict progression-free survival. In conclusion, angiogenic (interleukin-8), inflammatory (interleukin-6, high sensitivity C-reactive) and immunologic (myeloid-derived suppressor cells, percentage of T helper type 1 cells) markers at baseline would predict the response to sunitinib therapy and/or disease progression in patients with metastatic renal cell carcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
9. Novel algorithm for management of acute epididymitis.
- Author
-
Hongo, Hiroshi, Kikuchi, Eiji, Matsumoto, Kazuhiro, Yazawa, Satoshi, Kanao, Kent, Kosaka, Takeo, Mizuno, Ryuichi, Miyajima, Akira, Saito, Shiro, and Oya, Mototsugu
- Subjects
EPIDIDYMITIS ,LEUKOCYTE count ,C-reactive protein ,MEDICAL decision making ,SEVERITY of illness index ,THERAPEUTICS - Abstract
Objectives To identify predictive factors for the severity of epididymitis and to develop an algorithm guiding decisions on how to manage patients with this disease. Methods A retrospective study was carried out on 160 epididymitis patients at Keio University Hospital. We classified cases into severe and non-severe groups, and compared clinical findings at the first visit. Based on statistical analyses, we developed an algorithm for predicting severe cases. We validated the algorithm by applying it to an external cohort of 96 patients at Tokyo Medical Center. The efficacy of the algorithm was investigated by a decision curve analysis. Results A total of 19 patients (11.9%) had severe epididymitis. Patient characteristics including older age, previous history of diabetes mellitus and fever, as well as laboratory data including a higher white blood cell count, C-reactive protein level and blood urea nitrogen level were independently associated with severity. A predictive algorithm was created with the ability to classify epididymitis cases into three risk groups. In the Keio University Hospital cohort, 100%, 23.5%, and 3.4% of cases in the high-, intermediate-, and low-risk groups, respectively, became severe. The specificity of the algorithm for predicting severe epididymitis proved to be 100% in the Keio University Hospital cohort and 98.8% in the Tokyo Medical Center cohort. The decision curve analysis also showed the high efficacy of the algorithm. Conclusions This algorithm might aid in decision-making for the clinical management of acute epididymitis. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
10. Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma.
- Author
-
Obata, Jun, Tanaka, Nobuyuki, Mizuno, Ryuichi, Kanao, Kent, Mikami, Shuji, Matsumoto, Kazuhiro, Kosaka, Takeo, Kikuchi, Eiji, Jinzaki, Masahiro, and Oya, Mototsugu
- Subjects
PROGRESSION-free survival ,RENAL cell carcinoma ,KAPLAN-Meier estimator ,MULTIVARIATE analysis ,RENAL cancer ,PATIENTS - Abstract
Objectives To investigate the impact of perioperative plasma fibrinogen level as a biomarker of oncological outcome in localised renal cell carcinoma ( RCC). Patients and methods We consecutively identified 601 patients with localised RCC who underwent curative surgery at a single institution. Subsequent disease recurrence and cancer-specific survival ( CSS) were assessed using the Kaplan-Meier method. To evaluate the independent prognostic impact of plasma fibrinogen level, multivariate analysis was performed for these outcomes. Results Using the defined threshold level of preoperative plasma fibrinogen of ≥420 mg/ dL as elevated, we found 56 patients (9.3%) with an elevated plasma fibrinogen level preoperatively. In Kaplan-Meier analysis, there was a significant difference in disease-free survival and CSS rates between patients with and without preoperative plasma fibrinogen levels of ≥420 mg/ dL. Multivariate analysis showed that elevated preoperative plasma fibrinogen level was an independent predictor of subsequent disease recurrence and cancer-specific mortality. In a subgroup analysis of the elevated preoperative plasma fibrinogen level group, postoperative normalisation of plasma fibrinogen level was significantly associated with CSS, showing that patients with non-normalised plasma fibrinogen levels tended to have a higher incidence of cancer-specific mortality after surgery. Conclusion Patients with elevated preoperative plasma fibrinogen levels could be significantly predicted to have subsequent tumour metastasis and cancer-specific mortality, while there was a significant difference in CSS between patients in the normalised and non-normalised postoperative plasma fibrinogen groups. While these are hypothesis generating results, plasma fibrinogen levels may be a useful biomarker due to its low cost and ease of assessment. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
11. Optimal method for measuring tumor extent in needle biopsy specimens to identify small-volume prostate cancer.
- Author
-
Kajikawa, Keishi, Kanao, Kent, Kobayashi, Ikuo, Nishikawa, Genya, Yoshizawa, Takahiko, Kato, Yoshiharu, Watanabe, Masahito, Zennami, Kenji, Nakamura, Kogenta, and Sumitomo, Makoto
- Subjects
- *
TUMORS , *NEEDLE biopsy , *PROSTATE cancer , *PROSTATECTOMY , *CANCER research , *MULTIVARIATE analysis - Abstract
Objectives To compare various methods for measuring tumor extent in prostate biopsy specimens to identify small-volume prostate cancer. Methods A total of 100 radical prostatectomy specimens were retrospectively analyzed. Receiver operating characteristic analysis was used to compare the abilities of prostate-specific antigen density, and four measures of tumor extent in prostate biopsy specimens - positive core number, greatest percentage of cancer in a single core, greatest length of cancer in cores and total length of cancer in cores - to identify small volume prostate cancer. Four definitions of insignificant cancer volume were used in this analysis: index and total tumor volume <0.5 mL, index tumor volume <1.3 mL and total tumor volume <2.5 mL. Multivariate analysis was also used to evaluate variables for predicting small-volume prostate cancer. Results Total length of cancer in cores had the highest areas under the curve of all the measures defining small-volume prostate cancer: index tumor volume <0.5 mL (0.855), total tumor volume <0.5 mL (0.877), index tumor volume <1.3 mL (0.784) and total tumor volume <2.5 mL (0.818). On multivariate analysis total length of cancer in cores was an independent predictive factor for prostate cancers with index tumor volume <0.5 mL ( P < 0.001), <1.3 mL ( P < 0.001) and total tumor volume <0.5 mL ( P < 0.001), respectively. Conclusion Our data suggest that total length of cancer in cores is the optimal measure of tumor extent in prostate biopsy specimens for identifying small-volume prostate cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Comparative investigation on clinical outcomes of robot-assisted radical prostatectomy between experienced open prostatic surgeons and novice open surgeons in a laparoscopically naïve center with a limited caseload.
- Author
-
Sumitomo, Makoto, Kanao, Kent, Kato, Yoshiharu, Yoshizawa, Takahiko, Watanabe, Masahito, Zennami, Kenji, and Nakamura, Kogenta
- Subjects
- *
PROSTATECTOMY , *MEDICAL robotics , *PROSTATE surgery , *PROSTATE cancer , *KAPLAN-Meier estimator - Abstract
Objectives To compare perioperative, oncological and functional outcomes of robot-assisted radical prostatectomy between experienced and novice open radical prostatectomy surgeons in a laparoscopically naïve center with a limited caseload. Methods Six surgeons carried out robot-assisted radical prostatectomy in 154 patients, which were divided into the following three groups: group 1 ( n = 90), including patients operated on by a surgeon with experience in both open radical prostatectomy and robot-assisted radical prostatectomy; group 2 ( n = 36), including patients operated on by two surgeons with experience in open radical prostatectomy only; and group 3 ( n = 28), including patients operated on by three surgeons with limited experience in both open radical prostatectomy or robot-assisted radical prostatectomy. Results Groups 2 and 3 did not differ significantly in their median values of external blood loss ( P = 0.165) or console time ( P = 0.103). Positive surgical margin rates for pT2 patients were also similar in these two groups: 21.2% (7/33) in group 2 and 22.7% (5/22) in group 3 ( P = 0.894). Kaplan-Meier analysis showed that 12 months after robot-assisted radical prostatectomy the prostate-specific antigen-free rate for pT2 patients was 96.0% in group 2 and 100% in group 3, but the pad-free continence rate was just 91.0% in group 1, 88.0% in group 2 and 75.5% in group 3 (group 1 vs group 3, P = 0.037; group 2 vs group 3, P = 0.239). The major complication rate after robot-assisted radical prostatectomy was 3.3% (3/90) in group 1, 11.1% (4/36) in group 2 and 17.9% (5/28) in group 3 (group 1 vs group 3, P = 0.008; group 2 vs group 3; P = 0.441). Conclusions Robot-assisted radical prostatectomy offers satisfactory postoperative outcomes even when carried out by surgeons with limited experience in open radical prostatectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. Prognostic value of preoperative multiparametric magnetic resonance imaging ( MRI) for predicting biochemical recurrence after radical prostatectomy.
- Author
-
Hattori, Seiya, Kosaka, Takeo, Mizuno, Ryuichi, Kanao, Kent, Miyajima, Akira, Yasumizu, Yota, Yazawa, Satoshi, Nagata, Hirohiko, Kikuchi, Eiji, Mikami, Shuji, Jinzaki, Masahiro, Nakagawa, Ken, Tanimoto, Akihiro, and Oya, Mototsugu
- Subjects
PROSTATE cancer ,MAGNETIC resonance imaging ,PROSTATECTOMY ,REGRESSION analysis ,RADIOTHERAPY - Abstract
Objective To evaluate the suitability of preoperative multiparametric magnetic resonance imaging ( MRI) positivity as a predictor of biochemical recurrence after radical prostatectomy ( RP)., Patients and Methods We reviewed the clinical records of patients who underwent either standard RP or laparoscopic RP between January 2005 and December 2009 at our institution., Patients who received radiotherapy or androgen deprivation therapy before surgery were excluded. A total of 314 patients met the study inclusion criteria., Cox proportional hazard regression models were used for analyses., In accordance with the criteria in the established guidelines, a radiologist scored the probability of the presence of prostate cancer using a five-point scale of diagnostic confidence level. The highest confidence level of any pulse sequence was considered as the evaluation result., Results MRI positivity was significantly associated with a high clinical stage ( cT ≥ 2; P = 0.039), a high positive biopsy core rate (≥0.2; P < 0.001), a high biopsy Gleason score ([ GS] ≥8; P < 0.001) and a high pathological GS (≥8; P = 0.005)., Univariate analysis and multivariate analysis showed that MRI positivity was a prognostic indicator in the analysis that included only preoperative variables and also in the analysis including preoperative and pathological variables., Conclusion Multiparametric MRI positivity can independently predict biochemical recurrence after RP. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. Can transrectal needle biopsy be optimised to detect nearly all prostate cancer with a volume of ≥0.5 mL? A three-dimensional analysis.
- Author
-
Kanao, Kent, Eastham, James A., Scardino, Peter T., Reuter, Victor E., and Fine, Samson W.
- Subjects
- *
PROSTATE cancer , *BIOPSY , *MEDICAL simulation , *ANTERIOR pituitary gland , *PROSTATECTOMY - Abstract
Objective To investigate whether transrectal needle biopsy can be optimised to detect nearly all prostate cancer with a tumour volume ( TV) of ≥0.5 mL., Materials and Methods Retrospectively analysed 109 whole-mounted and entirely submitted radical prostatectomy specimens with prostate cancer., All tumours in each prostate were outlined on whole-mount slides and digitally scanned to produce tumour maps. Tumour map images were exported to three-dimensional (3 D) slicer software (http://www.slicer.org) to develop a 3 D-prostate cancer model., In all, 20 transrectal biopsy schemes involving two to 40 cores and two to six anteriorly directed biopsy ( ADBx) cores (including transition zone, TZ) were simulated, as well as models with various biopsy cutting lengths., Detection rates for tumours of different volumes were determined for the various biopsy simulation schemes., Results In 109 prostates, 800 tumours were detected, 90 with a TV of ≥0.5 mL (mean TV 0.24 mL)., Detection rate for tumours with a TV of ≥0.5 mL plateaued at 77% (69/90) using a 12-core (3 × 4) scheme, standard 17-mm biopsy cutting length without ADBx cores. In all, 20 of 21 (95%) tumours with a TV of ≥0.5 mL not detected by this scheme originated in the anterior peripheral zone or TZ., Increasing the biopsy cutting length and depth/number of ADBx cores improved the detection rate for tumours with a TVof ≥0.5 mL in the 12-core scheme., Using a 22-mm cutting length and a 12-core scheme with additional volume-adjusted ADBx cores, 100% of ≥0.5 mL tumours in prostates ≤ 50 mL in volume and 94.7% of ≥0.5 mL tumours in prostates > 50 mL in volume were detected., Conclusions Our 3 D-prostate cancer model analysis suggests that nearly all prostate cancers with a TV of ≥0.5 mL can be detected by 14-18 transrectal needle-biopsy cores., Using longer biopsy cutting lengths and increasing the depth and number of ADBx cores (including TZ) according to prostate volume are necessary as well. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
15. Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.
- Author
-
Tanaka, Nobuyuki, Kikuchi, Eiji, Kanao, Kent, Matsumoto, Kazuhiro, Kobayashi, Hiroaki, Miyazaki, Yasumasa, Ide, Hiroki, Obata, Jun, Hoshino, Katsura, Shirotake, Suguru, Hayakawa, Nozomi, Kosaka, Takeo, Miyajima, Akira, Momma, Tetsuo, Nakagawa, Ken, Hasegawa, Shintaro, Nakajima, Yosuke, and Oya, Mototsugu
- Subjects
TRANSITIONAL cell carcinoma ,DISEASE relapse ,CANCER chemotherapy ,NEPHRECTOMY ,MULTIVARIATE analysis - Abstract
Objectives To investigate oncological outcomes and prognostic factors in patients with upper tract urothelial carcinoma ( UTUC) who experienced disease recurrence after radical nephroureterectomy ( RNU)., Few studies have focused on the clinical courses of patients who experienced disease recurrence after RNU., Patients and Methods A total of 204 UTUC patients who experienced disease recurrence from a retrospective multi-institutional cohort were included in the present study., Associated patient outcomes were analyzed using multivariate analysis., Results The mean time from RNU to first disease recurrence was 15.0 months and ≈90% of patients experienced disease recurrence within the first 3 years after RNU., During a median follow-up of 8.1 month after disease recurrence, 165 patients died from UTUC and five patients died from other causes. In the 204 cohorts, 1- and 3-year cancer-specific survival rates were 40.2% and 9.7%, respectively, and 1- and 3-year overall survival rates were 39.5% and 9.4%, respectively., After disease recurrence, 132 patients underwent systemic chemotherapy, and a subgroup analysis of patients who underwent systemic chemotherapy multivariate analysis showed that performance status, the presence of liver metastasis and the number of recurrence sites were independently prognostic of cancer-specific and overall survival after relapsing., According to three significant variables, 1- and 3-year cancer-specific survival rates were 72.7% and 20.8% in patients with no risk factors, 46.5% and 7.5% in patients with one risk factor, and 26.4% and 4.4% in patients with two or three risk factors, respectively ( P < 0.001)., Conclusions Most patients died from UTUC within 3 years, even though systemic chemotherapies were administered after relapsing., Multivariate analysis showed that performance status, the presence of liver metastasis and the number of recurrence sites were independently related to poor survival after systemic chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
16. Predicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: Development of a novel pre-biopsy nomogram.
- Author
-
Ohigashi, Takashi, Kanao, Kent, Mizuno, Ryuichi, Kikuchi, Eiji, Nakashima, June, and Oya, Mototsugu
- Subjects
- *
PROSTATE cancer patients , *PROSTATE-specific antigen , *BIOPSY , *TUMORS , *QUANTITATIVE research - Abstract
Objectives: To develop and assess a new nomogram incorporating pre-biopsy clinical data to predict significant prostate cancer in Japanese men with a serum prostate-specific antigen (PSA) level of less than 10 ng/mL. Methods: We collected pre-biopsy data from 620 men with a serum total PSA of less than 10 ng/mL. They included 491 men with a negative biopsy and 129 men who were confirmed to have histological prostate cancer and subsequently underwent radical prostatectomy. Clinically significant tumors were defined as those with a tumor volume larger than 0.5 mL and/or a Gleason score of 7 or more. Results: One hundred and seven prostatectomy patients had clinically significant cancers. Stepwise multivariate logistic regression analysis showed that digital rectal examination findings, PSA adjusted for transition zone volume and free-to-total PSA ratio were the significant independent predictors of significant cancers ( P < 0.0001). Using these pre-biopsy independent factors, a nomogram was developed to predict significant cancers. According to a receiver operating characteristics analysis, the nomogram showed an area under the curve of 0.831. Conclusion: This represents the first nomogram to predict the probability of clinically significant cancers before biopsy. This tool is most likely to be useful in the management of patients with moderate to elevated PSA. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
17. Three-dimensional ultrasonography in evaluation of benign prostatic hyperplasia.
- Author
-
Kanao, Kent, Kikuchi, Eiji, Nakashima, Jun, Horiguchi, Yutaka, Nakagawa, Ken, Oya, Mototsugu, Ohigashi, Takashi, Marumo, Ken, and Murai, Masaru
- Subjects
- *
MEDICAL imaging systems , *BENIGN prostatic hyperplasia , *HYPERPLASIA , *PROSTATE -- Aging , *PROSTATE hypertrophy , *TRANSURETHRAL prostatectomy - Abstract
The clinical application of volume estimation by 3-D ultrasound has recently gained much attention. However, there have been no reports evaluating the prostate volume by 3-D transrectal ultrasound (TRUS) before transurethral resection of the prostate (TURP). The purpose of the present study was to evaluate the value of 3-D TRUS for prediction of prostate morphology and resected weight before TURP and to investigate whether 3-D TRUS is a more useful examination than 2D TRUS in patients with benign prostatic hyperplasia (BPH).Transurethral resection of the prostate was performed in 23 patients with BPH. We evaluated the prostate morphology and measured both the volumes of the whole prostate and the transition zone using 2-D and 3-D TRUS, respectively. The actual resected weight was recorded and compared with the volume of the whole prostate and that of the transition zone measured by 2D and 3-D TRUS.The volume of the transition zone measured by 3-D TRUS correlated most strongly with the resected weight (r = 0.84). A large median lobe was seen in three patients in whom the transition zone volume measured by 2-D TRUS was considerably larger than the resected weight. However, overestimation in the three patients decreased by the use of 3-D TRUS.It was concluded that 3-D TRUS was equal or superior to 2-D TRUS in prediction of the resected weight and 3-D TRUS offers better information as a diagnostic tool before TURP. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.